You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Loss of MMR

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

es to Capture the Real Life of Children With Rare Eye Diseases

Not yet recruiting
  • Eye Diseases
  • +3 more
  • Mixed Methods Research (MMR) using quantitative (QUAN) and qualitative (QUAL) tools
  • Strasbourg, France
    Centre de Référence pour les Affections Rares en Génétique Ophta
Oct 3, 2023

Lynch Syndrome Based on Next-generation Sequencing in Colorectal

Completed
  • Lynch Syndrome
  • next-generation sequencing
  • Fuzhou, Fujian, China
  • +6 more
Jul 14, 2021

Withdrawal of Second-generation Tyrosine Kinase Inhibitors After

Recruiting
  • MMR on 12 Month
  • Guangzhou, Guangdong, China
  • +1 more
Apr 21, 2022

Leukemia, Chronic Myelogenous Trial in China (asciminib, best available treatment)

Recruiting
  • Leukemia, Chronic Myelogenous
  • Chongqing City, Chongqing, China
  • +23 more
Jan 18, 2023

Sepsis Syndrome Trial in New Orleans (MMR vaccine)

Recruiting
  • Sepsis Syndrome
  • MMR vaccine
  • New Orleans, Louisiana
    Clinical and Translational Research Center
Apr 4, 2022

Meningitis, Meningococcal Trial in Worldwide (MenACYW conjugate vaccine, MMR, Varicella)

Completed
Has Results
  • Meningitis, Meningococcal
  • MenACYW conjugate vaccine
  • +4 more
  • Ansan, Korea, Republic of
  • +36 more
Mar 24, 2022

3rd Line Therapy or More to Treat Adult CML- CP in Real World

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Oct 16, 2023

Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Treatment-free Remission
  • TFR(Treatment-Free Remission)
  • (no location specified)
Jun 27, 2022

Withdrawal or Reduction TKIs in CML-CP

Recruiting
  • MMR on 12 Month
  • withdrawal TKIs or halve TKIs
  • Guangzhou, Guangdong, China
    NanfangH
Sep 2, 2021

Lynch Syndrome, Endometrial Tumors, Ovarian Tumors Trial in Toronto (Questionnaire, Educational Material)

Active, not recruiting
  • Lynch Syndrome
  • +3 more
  • Questionnaire, Educational Material
  • Toronto, Ontario, Canada
    University Health Network - Princess Margaret Hospital
May 16, 2022

Chronic Myelogenous Leukemia Trial in Worldwide (ABL001 40mg BID, ABL001 80mg QD, ABL001 200mg QD)

Recruiting
  • Chronic Myelogenous Leukemia
  • ABL001 40mg BID
  • +2 more
  • Caba, Buenos Aires, Argentina
  • +53 more
Jan 27, 2023

CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

Recruiting
  • CML
  • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
  • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
    FUNDALEU
Jun 29, 2023

Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)

Recruiting
  • Chronic Myelogenous Leukemia - Chronic Phase
  • Birmingham, Alabama
  • +25 more
Jan 10, 2023

Adenocarcinoma of the Colon Trial in London (Pembrolizumab)

Recruiting
  • Adenocarcinoma of the Colon
  • London, United Kingdom
    University College Hospital
Jul 20, 2022

Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)

Not yet recruiting
  • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
  • (no location specified)
Jul 11, 2022

Chronic Myeloid Leukemia Trial in Germany, Netherlands (TKI discontinuation, nilotinib)

Active, not recruiting
  • Chronic Myeloid Leukemia
  • Freiburg, Baden-Württemberg, Germany
  • +14 more
Nov 4, 2021

Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

Not yet recruiting
  • Chronic Myeloid Leukemia, BCR/ABL-Positive
    • Taipei, Taiwan
      National Taiwan University Hospital
    Jul 24, 2022

    Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

    Not yet recruiting
    • Tyrosine Kinase Inhibitors
    • Chronic Myeloid Leukemia
    • treatment of TKI in CML
    • Poitiers, France
      Chu Poitiers
    Feb 21, 2023

    Chronic Myeloid Leukemia, Chronic Phase Trial in Spain (Ponatinib 15 MG, Acetylsalicylic acid 100 MG)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Ponatinib 15 MG
    • Acetylsalicylic acid 100 MG
    • L'Hospitalet De Llobregat, Barcelona, Spain
    • +12 more
    Feb 8, 2022

    CML, Chronic Phase Trial in Harbin (Flumatinib mesylate tablets (400mg), Flumatinib mesylate tablets (600mg))

    Recruiting
    • CML, Chronic Phase
    • Flumatinib mesylate tablets (400mg)
    • Flumatinib mesylate tablets (600mg)
    • Harbin, Hei Longjiang, China
      Institute of Hematology and Oncology, Harbin The First Hospital
    Apr 28, 2022

    NSCLC Trial in Jette (68GaNOTA-Anti-MMR-VHH2)

    Recruiting
    • Non-small Cell Lung Cancer
    • Jette, Brussel, Belgium
      Universitair Ziekenhuis Brussel
    Jun 27, 2023

    Chronic Myeloid Leukemia Trial in Worldwide (Stopping treatment with TKI)

    Completed
    • Chronic Myeloid Leukemia
    • Stopping treatment with TKI
    • Brno, Czechia
    • +49 more
    Oct 29, 2021

    Transplantation, Hematopoietic Stem Cell Trial in Lyon (Biological samples (blood and oral fluid))

    Not yet recruiting
    • Transplantation, Hematopoietic Stem Cell
    • Biological samples (blood and oral fluid)
    • Lyon, France
      Hôpital de la Croix Rousse - service des maladies infectieuses e
    Jul 7, 2023

    Leukemia, Chronic Myelogenous Trial in Japan (Bosutinib)

    Completed
    Has Results
    • Leukemia, Chronic Myelogenous
    • Toyoake-City, Aichi, Japan
    • +20 more
    Apr 26, 2022

    Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib followed by treatment-free)

    Active, not recruiting
    Has Results
    • Chronic Myelogenous Leukemia
    • Nilotinib followed by treatment-free
    • Fort Myers, Florida
    • +113 more
    Apr 25, 2022